Profile of Escherichia coli infections in hospitalized patients between 2019 and 2025 in Brazil: An integrative review
DOI:
https://doi.org/10.33448/rsd-v14i11.50124Keywords:
Hospital Infection, Escherichia coli, Epidemiology, Bacterial Resistance.Abstract
The objective of this study was to describe the profile of Escherichia coli infections in hospitalized patients in Brazil from 2019 to 2025, highlighting their epidemiological characteristics, resistance mechanisms, and control strategies in healthcare services. Methodology: This is an integrative review based on Evidence-Based Practice (EBP), conducted in the SciELO, PubMed, and Web of Science databases, using inclusion criteria defined between January 2019 and August 2025. Results: Ten cross-sectional studies were selected, grouped into four thematic categories: resistance profile, treatment, clinical evolution, and characteristics of the affected population. The results revealed a predominance of extended-spectrum β-lactamase (ESBL)-producing strains, a high rate of multidrug resistance, and a higher incidence in vulnerable groups, such as neonates, the elderly, immunosuppressed individuals, and cancer patients. Conclusion: It is concluded that controlling E. coli infections in the hospital setting depends on continuous epidemiological surveillance, the adoption of preventive protocols, and the rational use of antimicrobials, guided by microbiological tests. These findings reinforce the need for institutional and national policies aimed at reducing bacterial resistance and ensuring patient safety.
References
Alhadlaq, M. A. et al. (2024). Overview of pathogenic Escherichia coli, with a focus on serotypes and outbreaks. Frontiers / Review. https://pmc.ncbi.nlm.nih.gov/articles/PMC11457481/.
Baroud, M. J.; et al. (2013). Underlying mechanisms of carbapenem resistance in Enterobacterales. International Journal of Medical Microbiology.
Bittencourt, A. A. et al. (2024). Activity of ceftolozane/tazobactam and comparators against Enterobacterales in Brazil. Journa. https://pmc.ncbi.nlm.nih.gov/articles/PMC11699052/.
Brasil. (2023).. Plano Nacional para a Prevenção e o Controle da Resistência aos Antimicrobianos nos Serviços de Saúde – PAN-Serviços 2023-2027. Brasília: Agência Nacional de Vigilância Sanitária (ANVISA).
Castro, E. M. et al. (2025). Emergency and persistence of Escherichia coli ST131 as community-onset antimicrobial resistant urinary tract infection in Rio de Janeiro, Brazil. Brazilian Journal of Infectious Diseases. 29(4), 104555. Doi: 10.1016/j.bjid.2025.104555.
Cbsmed. (2022). Imagem 002524. Website Cbsmed. https://cbsmed.com.br/wp-content/uploads/2022/11/002524.jpg.
(2025). Healthcare-Associated Infections (HAIs) — resource and guidance pages. Centers for Disease Control and Prevention (CDC), 2024–2025. https://www.cdc.gov/healthcare-associated-infections/index.html.
França, F. R. et al. (2020). Incidência de infecção relacionada à assistência à saúde na Unidade de Terapia Intensiva de um hospital de médio porte. Revista Funec Científica – Multidisciplinar. 9(11). Doi: https://doi.org/10.24980/rfcm.v9i11.4034.
Galdino, C. V. et al. (2023). Avaliação da prevalência de infecção hospitalar e o perfil de resistência bacteriana das cepas isoladas na UTI neonatal da Maternidade Escola de Valença – RJ. Revista Saber Digital, v. 16, n. 2, e20231606. Doi: 1024859/SaberDigital.2023v16n2.1434.
Genário, L. R. et al. (2022). Resistência antimicrobiana na infecção urinária em unidade de terapia intensiva. Arquivos de Ciências da Saúde da UNIPAR. 26(3), 1325-42. Doi: 10.25110/arqsaude.v26i3.20229007.
Geurtsen, J. et al. (2022). Genomics and pathotypes of the many faces of Escherichia coli. FEMS Microbiology Reviews. 46. https://academic.oup.com/femsre/article/46/6/fuac031/6617594.
Gima, M. B. S. et al. (2020). Características microbiológicas e perfil de resistência de microrganismos causadores de infecções hospitalares em uma UTI para pacientes pediátricos de um hospital referência em infectologia do Amazonas. Brazilian Journal of Health Review. 3(4), 8663-78. Doi: 10.34119/bjhrv3n4-114.
GLOBALE STUDY: Murray, C. J. L. et al. (2022). Global burden of bacterial antimicrobial resistance in 2019. The Lancet. https://pmc.ncbi.nlm.nih.gov/articles/PMC8841637/.
Huang, J. et al. (2024). Carbapenem-resistant Escherichia coli exhibit diverse resistance mechanisms and global spread. Frontiers / Journal (ou similar).https://pmc.ncbi.nlm.nih.gov/articles/PMC10771496/.
Kaper, J. B., Nataro, J. P. & Mobley, H. L. T. (2004). Pathogenic Escherichia coli. Nature Reviews Microbiology. 2, 123–40. https://www.nature.com/articles/nrmicro818.
Kasvi. (2025). Líquido Cefalorraquidiano: fatores pré-analíticos que influenciam sua análise. Imagem no website Kasvi. https://kasvi.com.br/liquido-cefalorraquidiano-fatores-pre-analiticos-analise/.
Klein, R. D. & Hultgren, S. J. (2020). Urinary tract infections: microbial pathogenesis, host responses, and new treatment strategies. Nature Reviews Microbiology. https://pmc.ncbi.nlm.nih.gov/articles/PMC7942789/.
Leite, M. S. et al. (2020). Perfil de resistência aos antimicrobianos de Escherichia coli isoladas de amostras de urina de pacientes de uma Unidade de Terapia Intensiva. RBAC. 52(3), 243-7. Doi: 10.21877/2448-3877.202100877.
Mendes, K. D. S., Silveira, R. C. C. P. & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto contexto –enfermagem. 17(4),758-64.
Mueller, M. et al. (2023). Escherichia coli Infection. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK564298/.
Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019. The Lancet. Doi: 10.1016/S0140- 6736(21)02724-0.
Oliveira, J. S. et al. (2019). Avaliação da resistência antimicrobiana nas infecções hospitalares de um hospital de Maceió. Centro Universitário Tiradentes – UNIT, Maceió.
Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. [free ebook]. Santa Maria. Editora da UFSM.
Pillonetto, M. et al. (2021). The experience of implementing a national antimicrobial surveillance program (BR-GLASS) in Brazil. Frontiers in Public Health. https://www.frontiersin.org/articles/10.3389/fpubh.2020.575536/full.
Simplicio, I. O. B. et al. (2021). Caracterização das infecções relacionadas à assistência à saúde em hospital localizado no baixo Amazonas, Brasil. Enfermagem Brasil. 20(5), 627-38. Doi: https://doi.org/10.33233/eb.v20i5.4735.
SIlva, L. E. P. et al. (2021). Perfil microbiológico de culturas de pacientes internados em UTIs de uma unidade hospitalar referência em doenças infectocontagiosas. Revista Feridas. 9(48), 1770-6.
Snyder, H. (2019). Literature review as a reSearch methodology: An overview and guidelines. Journal of Business Research. 104, 333-9. Doi: https://doi.org/10.1016/j.jbusres.2019.07.039.
Sonikamx. (2021). Imagem SPROTTE_PAJUNK. Website Sonikamx. https://www.sonikamx.com/wp-content/uploads/2021/03/SPROTTE_PAJUNK-1024x384.jpeg
Todescatto, G. C., Salame, A. L. & Dalzochio, T.(2022). Prevalência de bactérias com diferentes mecanismos de resistência antimicrobiana em amostras de swabs de vigilância de pacientes internados em uma unidade hospitalar de Nova Prata, RS. Revista Saúde. 48(2). Doi: 10.5902/2236583471277.
Vila, J. et al. (2016). Escherichia coli: an old friend with new tidings. FEMS Microbiology Reviews. 40(4), 437–63. https://pubmed.ncbi.nlm.nih.gov/28201713/.
Wilson, H. et al. (2018). Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales: mechanisms and genomic epidemiology. Clinical Microbiology Reviews. https://pmc.ncbi.nlm.nih.gov/articles/PMC6113871/.
WHO. (2025). Infection prevention and control. World Health Organization (WHO). https://www.who.int/teams/integrated-health-services/infection-prevention-control.
WHO. (2022). Global antimicrobial resistance and use surveillance system (GLASS) report: 2022.
Genebra: World Health Organization (WHO). WHO GLASS.
Zavaski, G. G. et al. (2024). Prevalência de infecções bacterianas multirresistentes em pacientes sob tratamento oncológico. Brazilian Journal of Implantology and Health Sciences. 6(10), 2405-19. Doi: https://doi.org/10.36557/2674- 8169.2024v6n10p2405-2419.Z
Zou, Y. et al. (2023). Uropathogenic Escherichia coli (UPEC) and urinary tract infections review. International Journal of Molecular Sciences. 24. https://www.mdpi.com/1422-0067/24/13/10537.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Geovana Cabral Alves, Cássia da Silva Rêgo Marcolino, Ivila Lorrani da Costa Cavalcante , Marina Alves dos Reis , Denilson de Araújo e Silva, Leonardo Guedes Rodrigues
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
